More recently, a series of hotspot mutations within ENL’s YEATS domain have been identified in 5–9% of Wilms tumor patients32, making ENL the most frequently mutated epigenetic regulator in this disease20,32. This evidence concerns the gene MLLT1 and Wilms tumor.